Phathom Pharmaceuticals, Inc.
Institutional Ownership & Holdings Analysis
About
phathom-pharmaceuticals is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | Frazier Life Sciences Management, L.P.(2025-03-31) | $63.4M |
2 | Medicxi Ventures Management (Jersey) Ltd(2025-03-31) | $46.8M |
3 | JENNISON ASSOCIATES LLC(2025-03-31) | $44.2M |
4 | Carlyle Group Inc.(2025-03-31) | $21.9M |
5 | BlackRock, Inc.(2025-03-31) | $20.8M |
6 | Checkpoint Capital L.P.(2024-12-31) | $18.5M |
7 | VANGUARD GROUP INC(2025-03-31) | $17.4M |
8 | Ensign Peak Advisors, Inc(2025-03-31) | $15.8M |
9 | NEA Management Company, LLC(2025-03-31) | $12.3M |
10 | WASATCH ADVISORS LP(2025-03-31) | $10.7M |
11 | 683 Capital Management, LLC(2025-03-31) | $9.1M |
12 | TANG CAPITAL MANAGEMENT LLC(2025-03-31) | $7.5M |
13 | Catalys Pacific, LLC(2025-03-31) | $7.3M |
14 | Propel Bio Management, LLC(2025-03-31) | $7.1M |
15 | GW&K Investment Management, LLC(2025-03-31) | $6.9M |
16 | MORGAN STANLEY(2025-03-31) | $6.6M |
17 | GEODE CAPITAL MANAGEMENT, LLC(2025-03-31) | $6.4M |
18 | STATE STREET CORP(2025-03-31) | $5.7M |
19 | Decheng Capital LLC(2024-12-31) | $5.6M |
20 | Avidity Partners Management LP(2025-03-31) | $5.0M |
As of 2025-03-31
Value:$63.4M
As of 2025-03-31
Value:$46.8M
As of 2025-03-31
Value:$44.2M
As of 2025-03-31
Value:$21.9M
As of 2025-03-31
Value:$20.8M
As of 2024-12-31
Value:$18.5M
As of 2025-03-31
Value:$17.4M
As of 2025-03-31
Value:$15.8M
As of 2025-03-31
Value:$12.3M
As of 2025-03-31
Value:$10.7M
As of 2025-03-31
Value:$9.1M
As of 2025-03-31
Value:$7.5M
As of 2025-03-31
Value:$7.3M
As of 2025-03-31
Value:$7.1M
As of 2025-03-31
Value:$6.9M
As of 2025-03-31
Value:$6.6M
As of 2025-03-31
Value:$6.4M
As of 2025-03-31
Value:$5.7M
As of 2024-12-31
Value:$5.6M
As of 2025-03-31
Value:$5.0M
Total Institutional Holders:170
Top 10 Holders Own:65.7%